US PE Firms Pivot to Smaller Deals as Q2 Volume Jumps 56% to $16 Billion
Middle-market buyout activity shifts toward smaller, founder-owned businesses as firms seek lower entry multiples and navigate an exit bottleneck in the larger-cap…
Middle-market buyout activity shifts toward smaller, founder-owned businesses as firms seek lower entry multiples and navigate an exit bottleneck in the larger-cap…
Tech-heavy indices retreated as hardware makers faced selling pressure, while cybersecurity and software stocks gained on hopes that a slowdown in AI…
HPE shares surged 4% as investors prioritized AI networking growth and Oracle-backed order visibility over valuation-based analyst downgrades, while the broader server…
Cybersecurity stocks rally as AI safety concerns trigger a broader tech sector rotation, with investors betting on increased demand for digital protection…
Target's successful turnaround and status as a Dividend King make it a compelling buy, as the retailer's 60% year-to-date performance leaves Nvidia's…
Vista Energy stock rallies toward a new buy point, driven by surging oil prices and heightened geopolitical tensions in the Middle East,…
Semiconductor shares face downward pressure as industry executives advocate for a more cautious approach to AI development to mitigate potential safety risks.
Jim Cramer warns that a potential slowdown in data center construction, fueled by calls for moderated AI development, poses a significant risk…
XRP consolidates around $1.35, with analysts eyeing a breakout above $1.38 to trigger a rally toward $1.60, provided the token maintains support…
Michael Dell's 40% stake in his company has propelled him past Jeff Bezos in global wealth rankings, highlighting how ownership structure dictates…
Robinhood's dominance in the youth market and 28% deposit growth drive bullish sentiment, though analysts warn that high valuations and regulatory risks…
Veradermics and Absci lead a surge in hair-loss drug stocks, though clinical risks and the lack of insurance coverage for cosmetic treatments…